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Sterol 3b-glucosyltransferase biocatalysts with a range
of selectivities, including selectivity for testosterone
Vatsala Malik,a Meng Zhang,a Lynn G. Dover,a Julian S. Northen,b Anthony Flinn,b
Justin J. Perrya and Gary W. Black*a
The main objectives of this work were to characterise a range of purified recombinant sterol
3b-glucosyltransferases and show that rational sampling of the diversity that exists within sterol
3b-glucosyltransferase sequence space can result in a range of enzyme selectivities. In our study the
catalytically active domain of the Saccharomyces cerevisiae 3b-glucosyltransferase was used to mine
putative sterol 3b-glucosyltransferases from the databases. Selected diverse sequences were expressed
in and purified from Escherichia coli and shown to have diﬀerent selectivities for the 3b-hydroxysteroids
ergosterol and cholesterol. Surprisingly, three enzymes were also selective for testosterone, a 17b-hydroxysteroid.
This study therefore reports for the first time sterol 3b-glucosyltransferases with selectivity for both 3b- and
17b-hydroxysteroids and is also the first report of recombinant 3b-glucosyltransferases with selectivity for
steroids with a hydroxyl group at positions other than C-3. These enzymes could therefore find utility in the
pharmaceutical industry for the green synthesis of a range of glycosylated compounds of medicinal interest.
Introduction
Many lead compounds under development by the pharmaceutical
industry are poorly water soluble and hence have non-ideal
pharmacokinetic properties. One strategy, to overcome this
problem is to link the drug substance to a water soluble moiety
such as a carbohydrate, as the drug can be cleaved from this
adduct by normal metabolic processes, ideally at the desired site
of action. For example, the oral pro-drug testosterone-glucoside
is currently under investigation by ProStrakan as an alternative
to testosterone for patients suﬀering from hypogonadism.1
Glycosidic derivatives are also of interest because they are
commonly encountered in the in vivo metabolism of xenobiotic
compounds as more water soluble products more suitable for
excretion. Consequently, synthesis of appropriate carbohydrate
derivatives might be employed to provide either more eﬀective
medicinal compounds or as a means to investigate drug pharma-
cokinetics through adsorption, distribution, metabolism and
excretion (ADME) of a drug substance.2
Chemical methods of glycosylation are challenging and usually
require a laborious protection–deprotection strategy which drives
down overall chemical yield especially with complex aglycones.3,4
In addition, this approach proves industrially unattractive due to
the formation of intractable mixtures of side-products.3,4 In
contrast, the chemo- and regioselective glycosylation of hydroxyl
functionality is a common biotransformation and several glycosyl-
transferase (GTase) biocatalysts that perform efficient and
selective conversions have been characterised.5 The majority of
characterised GTases catalyze the transfer of the monosaccharide
units from an activated nucleotide donor, such as a uridine
diphosphate sugar, to specific acceptor molecules, during the
formation of a glycosidic bond.6
Glucosylation of steroids with a hydroxyl group at the C-3
position is a common biotransformation catalyzed by GTases
known as sterol 3b-glucosyltransferases (systematic name, uridine
diphosphate-glucose:sterol 3-O-b-D-glucosyltransferases; abbrevia-
tion, UDPG-SGTases; EC number, 2.4.1.173). UDPG-SGTase are
members of GTase family 1 (GT1) of the Carbohydrate Active
Enzymes database; a database that classifies enzymes that degrade,
modify, or create glycosidic bonds into distinct protein sequence
homology-based families.7 Characterized examples of UDPG-
SGTases include UGT51 from Saccharomyces cerevisiae and UGT51B1
from Pichia pastoris.8 UGT51 and UGT51B1 each contain a GT1 GT-
like conserved domain (cd03784) and pleckstrin homology/GRAM
conserved domains (cd13215 and cd13216) that are often involved in
targeting proteins to the plasma membrane.9–11 Warnecke et al.8
also showed, by successively deleting the N-terminus of UGT51,
followed by in vitro analysis, that it is only the GT1 GT-like conserved
domain that is responsible for UDPG-SGTase activity.
There are several reports of characterised UDPG-SGTases,
but many of these were performed with crude homogenate,
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purified membrane or partially purified enzyme preparations
that may have contained mixtures of UDPG-SGTases.12
Unfortunately, there are only a few reports of characterised
recombinant UDPG-SGTases.12 Our work therefore aimed to
characterise a range of recombinant UDPG-SGTase catalytic
domains, identified via sequence similarity to that of UGT51.
Additionally, we aimed to show that rational sampling of the
diversity that exists within sequence space, i.e. the number of
possible amino acid sequences that can generate a particular
enzyme activity, results in a range of enzyme selectivities. We show
that a range of selectivities, including specificity for testosterone, a
17b-hydroxysteroid, were present among the six recombinant
UDPG-SGTases that were characterised in this study.
Results and discussion
Identification of putative GT1 GT-like domains
Diﬃculties in producing and characterising GTases are well-
documented and are associated with the presence of non-catalytic
domains involved in membrane spanning13 or non-integral
membrane associations, such as the pleckstrin homology/GRAM
domains.9–11 Therefore the N-terminally truncated catalytic
domains, comprising of only the GT1 GT-like domain of several
UDPG-SGTases were expressed in E. coli. This was achieved by
conducting a BLASTP search using the amino acid sequence of the
shortest C-terminal domain of the S. cerevisiaeUGT51 that encoded
a catalytically active UDPG-SGTase.8 The BLASTP search revealed
similarities with the previously characterised UDPG-SGTase,
UGT51B1 from P. pastoris, and several uncharacterised protein
products. Fig. 1 shows the ClustalW2 multiple sequence alignment
(version 2.1) comparison of the deduced N-terminally truncated
domains of the sequences selected from the BLASTP search. The
catalytic UDPG-SGTase domain of the S. cerevisiae UGT51, UGT510,
is comprised of a polypeptide of 475 amino acids.8,11 This domain
has 61–64% identity to the C-terminal domains of the selected
sequences: UGT51B1 of P. pastoris (termed UGT51B10), A7KAK6 of
P. angusta (termed A7KAK60), A5DNB9 of M. guilliermondii (termed
A5DNB90), Q6BN88 of D. hansenii (termed Q6BN880) and Q6CUV2
of K. lactis (termed Q6CUV20); with the selected proteins showing a
good level of sequence space diversity, i.e. 58–66% identity amongst
themselves. Gene fragments corresponding to deletions of 723, 747,
770, 1065, 1030 and 718 codons from the 50 end of the sequences
encoding UGT51, UGT51B1, A7KAK6, A5DNB9, Q6BN88 and
Q6CUV2, respectively, were amplified, cloned and expressed in
E. coli. The N-terminal residues of these sequences showed low
levels of sequence identity (between 18–35%).
Expression of putative UDPG-SGTases using a range
of E. coli BL21(DE3) strains
The N-terminally hexa-histidine tagged protein products with a
calculated molecular mass of 54.6 kDa for UGT510, 53.5 kDa for
UGT51B10, 54.2 kDa for A7KAK60, 60.6 kDa for A5DNB90,
61.8 kDa for Q6BN88 0 and 55.9 kDa for Q6CUV20 were
expressed in E. coli BL21(DE3) strains. In all cases the largest
amount of soluble protein expression was achieved after 18 h of
post-induction growth at 23 1C and no expression was observed
in the absence of induction with isopropyl-1-thio-b-D-galacto-
pyranoside. In two cases, UGT510 and A5DNB90, low expression
levels in E. coli BL21(DE3) were seen (data not shown). To
maximise expression of these genes E. coli BL21(DE3) CodonPlus
strains were transformed with the LIC-constructs encoding
UGT510 and A5DNB90. Following this, increase in recombinant
protein expression levels was observed for A5DNB90 and UGT510
encoding plasmids transformed in E. coli BL21(DE3) CodonPlus
(RP) and E. coli BL21(DE3) Codon Plus (RIPL), respectively (data
not shown). All gene fragments encoded soluble protein products
(with yields between 10–100 mg L1) were purified using
immobilised metal ion (Ni2+) chromatography. Multiple non-
redundant peptides were identified by peptide fragmentation
fingerprinting of UGT510, UGT51B10, A7KAK60, A5DNB90,
Q6BN880 and Q6CUV20; confirming the identity of the purified
proteins (data not shown).
Identification of UDPG-SGTases with diﬀerent selectivities
Each of the six recombinant proteins was assayed for activity
against the following steroidal acceptors: ergosterol, cholesterol,
estrone, estradiol, androstenedione and testosterone (Table 1).
UGT510 from S. cerevisiae was shown to be active against the
3b-hydroxysteroids, cholesterol and ergosterol (Fig. 2A and B,
respectively); confirming the results seen by Warnecke et al.8
and revealing that activity is also observed with a purified
N-terminally hexa-histidine tagged version of the enzyme.
UGT51B10 from P. pastoris was also active against the
3b-hydroxysteroids (Fig. 2A and B); again confirming the results
seen by Warnecke et al.8 and revealing that it is only the GT1
GT-like domain of the P. pastoris enzyme that is responsible for
UDPG-SGTase activity. The N-terminally truncated previously
uncharacterised enzyme, A7KAK6, from P. angusta was also
shown to be active against the 3b-hydroxysteroids (Fig. 2A and
B); adding further support to the suggestion that it is only the
GT1 GT-like domain of UDPG-SGTases that is responsible for
activity. The N-terminally truncated previously uncharacterised
enzyme, Q6CUV2, from K. lactis was shown to be active against
cholesterol (Fig. 2A) but not against ergosterol (data not
shown). Interestingly, UGT510, UGT51B10 and A7KAK60 were
also shown to be active against the 17b-hydroxysteroid, testos-
terone (Fig. 2C) and to our knowledge this is the first report of
UDPG-SGTases with activity against both 3b- and 17b-hydroxyl
steroids. In fact, any reports of UDPG-SGTases with specificity
towards glucosylation of steroids at positions other than C-3 are
limited and importantly none involving the characterisation of
a recombinant enzyme have been reported. For example,
Madina et al.14 have shown that a near to pure 27b-hydroxy
glucosyltransferase from the cytosolic fraction of the medicinal
plant, Withania somnifera, showed activity against testosterone;
Poppenberger et al.15 have shown that wild-type seedlings
of Arabidopsis converted the brassinosteroid brassinolide to the
23-O-glucoside, but in the transgenic plants silenced in UGT73C5
expression no 23-O-glucoside was detected; and O’Reilly et al.16
have shown that a baculovirus ecdysteroid UDP-glucosyltransferase
produces ecdysone 22-O-b-D-glucopyranoside.
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As expected, the UDPG-SGTases in this study exhibited no
activity towards b-naphthol, a non-steroidal aromatic alcohol;
estrone and estradiol, hydroxysteroids with the OH group at the
C-3 position in a flat configuration; and androstenedione, a
steroid with a similar structure to testosterone but with no OH
group at the C-17 position (data not shown). Additionally, the
other two N-terminally truncated UDPG-SGTases expressed in
this study, A5DNB90 from M. guilliermondii and Q6BN88 0 from
D. hansenii did not demonstrate activity towards any of the
acceptors used, even though they have previously been implicated
in autophagy and related processes.17,18 UDP-galactose was found
not to be accepted as the sugar donor for any of the UDPG-SGTases
with any of the screened acceptors. This was in accordance with
previous studies where similar specificity for donor sugars has
been reported for S. cerevisiae and other eukaryotic GTases.8 It
is worth noting that while using testosterone as the steroidal
acceptor, glucosylated products had similar Rf values to an
authentic b-testosterone glucoside standard (data not shown).
This was further confirmed by co-spotting of reaction products
with the standard (data not shown).
LC-MS analysis was used to confirm the results from the TLC
experiments. Characteristic signals for the monoprotonated
testosterone (m/z = 289 with a retention time of 2.0 min) and
monoprotonated testosterone glucoside (m/z = 451 with a
Fig. 1 Clustal W2 multiple sequence alignment of the deduced N-terminally truncated catalytic domains of the UDPG-SGTases expressed in this study. UGT51B10 ,
P. pastoris UDPG-SGTase; A7KAK6 0 , P. angusta UDPG-SGTase; A5DNB90 , M. guilliermondii UDPG-SGTase; Q6BN88 0 , D. hansenii UDPG-SGTase; UGT510 , S. cerevisiae
UDPG-SGTase; Q6CUV2 0 , K. lactis UDPG-SGTase. Black boxes indicate identical amino acids in all 6 sequences. Grey boxes indicate identical amino acids in 4 or 5
sequences. The alignment was conducted with residues 724 to 1198 of UGT510 , 748 to 1211 of UGT51B1, 771 to 1241 of A7KAK6, 1066 to 1599 of A5DNB9, 1031 to
1574 of Q6BN88, and 719 to 1209 of Q6CUV2.
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retention time of 1.4 min) were determined using authentic
standards. Both were observed in the reaction mixture after 2 h
(Fig. 3) but after an overnight incubation only the peak for the
testosterone glucoside could be observed. This was also sup-
ported by TLC analysis of an overnight incubation with testo-
sterone (data not shown) and was also the case for cholesterol
and ergosterol overnight incubations (data not shown). An
added advantage to this analytical method was that testosterone
and the corresponding glucosylated compound were separated
by a chromatographic method with a run time of 5 min at room
temperature, an assay which compares favourably with previous
studies where separation was achieved with longer retention
times at elevated column temperatures.19,20
Kinetic analysis of UDPG-SGTases
Kinetic analysis was performed for all active UDPG-SGTases using
cholesterol and testosterone as acceptors and UDP-[14C] glucose as
the donor. All reactions demonstrated classic Michaelis–Menten
kinetics with goodness-of-fit statistical analysis of the linear
trend lines of the resulting Lineweaver–Burke plots producing
R2 values between 0.8052 to 0.9599 (data not shown). For
enzymes active against cholesterol and testosterone, the binding
capacity of the enzymes for cholesterol was higher (Z4.5-fold)
than that for testosterone (Table 2). Similarly, the reaction rate of
the enzymes active against cholesterol was higher (Z1.8-fold)
Table 1 Chemical structures of steroids that were used in this study
Acceptor substrate Structure
Ergosterol
Cholesterol
Estrone
Estradiol
Androstenedione
Testosterone
Fig. 2 Thin layer chromatograms of extracted reaction products following 2 h
incubations. Reaction products of UGT51B10 , P. pastoris UDPG-SGTase; A7KAK6 0 ,
P. angusta UDPG-SGTase; UGT510 , S. cerevisiae UDPG-SGTase; Q6CUV2 0 , K. lactis
UDPG-SGTase using cholesterol (panel A), ergosterol (panel B) and testosterone
(panel C) as acceptors. Lanes C, T and E are the cholesterol, testosterone and
ergosterol controls, respectively, without enzyme. CG, TG and EG are cholesterol
glucoside, testosterone glucoside and ergosterol glucoside, respectively.
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than that against testosterone (Table 2). It should be noted that
the apparent Km values of the enzymes with testosterone were
derived at less than saturating substrate concentrations due
to the lack of solubility of testosterone at higher concentrations
in the aqueous reaction mixture. UGT51B1 0 from P. pastoris
displayed the highest level of apparent catalytic efficiency
(kcat/Km value) on both substrates (Table 2) and its catalytic
efficiency against testosterone was comparable to that of the
plant 27b-hydroxy glucosyltransferase against testosterone.21
The presence of Mn2+ ions was shown not to affect the activity
Fig. 3 LC-chromatogram and MS spectrum of extracted reaction products. Extraction from P. angusta UDPG-SGTase A7KAK6 0 catalysed reaction following a 2 h
incubation. A characteristic peak at m/z = 451 [M + H]+ at a retention time (RT) of 1.38 min confirms the synthesis of testosterone glucoside (inset). Peak at retention
time 2.06 (m/z = 289 [M + H]+) shows the residual testosterone in the reaction mixture. Selected ion monitoring mode of m/z = 288.0–290.0 and 450.0–452.0
was used.
Table 2 Kinetic parameters of the UDPG-SGTases. C, cholesterol; T, testosterone. Results are the means of triplicated determinations  standard error. Km values of
the enzymes against testosterone were derived at less than saturating substrate concentrations due to the lack of solubility of testosterone at higher concentrations in
the aqueous reaction mixture
UDPG-SGTase Acceptor Km (mM) Vmax (mmol min
1 mg1) kcat (s
1) kcat/Km (s
1 mM1)
UGT510 C 79.9  21.7 1447.0  218.2 1319.2 16.5
T 362.5  26.85 538.7  23.75 491.13 1.35
UGT51B10 C 34.90  10.80 4337  551.2 3897.0 111.6
T 211.1  27.5 288.7  20.5 488.67 2.3
A7KAK60 C 67.2  31.63 719.1  176.8 650.6 9.7
T 837.9  182.23 540.1  76.24 351.9 0.42
Q6CUV20 C 65.92  31.09 509.0  124.6 475.0 7.21
Molecular BioSystems Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 3
0 
A
ug
us
t 2
01
3.
 D
ow
nl
oa
de
d 
on
 0
9/
10
/2
01
3 
11
:4
6:
20
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
This journal is c The Royal Society of Chemistry 2013 Mol. BioSyst., 2013, 9, 2816--2822 2821
of the enzymes in this study (data not shown) which is in
agreement with that of the Madina et al.14 who have reported
that the presence of Mn2+ ions did not affect the activity of the
plant 3b-glucosyltransferase.
Conclusions
We have shown that the approach of rational sampling of the
diversity that exists within sequence space identified via a
BLAST search generated a range of UDPG-SGTases with the
same activity but diﬀerent selectivity. We suggest that this class of
enzyme could become valuable biocatalysts in the pharmaceutical
industry (and fine chemical industry) due to their ability to
glycosylate a range of sterols without the need to use protection–
deprotection strategies.
Experimental
Yeast strains and propagation
Saccharomyces cerevisiae (ATCC 204508) and Pichia pastoris
(ATCC 201178) were obtained from the LGC Standards (UK).
Pichia angusta (DSM 70277), Meyerozyma guilliermondii (DSM
6381) and Kluyveromyces lactis (DSM 70799) were obtained from
DSMZ (Germany). Debaryomyces hansenii (CBS 767) was obtained
from the CBS Fungal Biodiversity Centre (Netherlands). S. cerevisiae
and P. pastoris were grown overnight at 30 1C, 100 rpm in yeast
extract peptone dextrose medium (2% [w/v] Bacto Peptone [BD,
UK], 1% [w/v] yeast extract [Oxoid, UK], 2% [w/v] glucose [Sigma,
UK]) whereas the other strains were grown overnight at 25 1C,
100 rpm in yeast extract–malt extract medium (0.3% [w/v] yeast
extract [Oxoid, UK], 0.3% [w/v] malt extract [Oxoid, UK], 0.5%
peptone [Oxoid, UK], 1% [w/v] glucose [Sigma, UK]).
Identification and cloning of UDPG-SGTase encoding genes
A BLASTP (version 2.2.27)22 search of the databases was con-
ducted using UGT510 (residues 724 to 1198 of UGT51) as a
query to identify similar sequences. Gene sequences encoding
N-terminal truncated versions of the proteins identified were
selected via rationally sampling the diversity that exists within
sequence space. The selected genes (Table 3 for UniProtKB
accession numbers) were then cloned and expressed in Escherichia
coli. Genomic DNA was prepared from overnight cultures using the
DNeasy Blood and Tissue Kit [Qiagen, UK] and the primer pairs
[Eurofins MWG Operon, Germany], shown in Table 3, were used to
amplify the gene fragments via PCR using KOD Hot Start DNA
Polymerase [Merck Chemicals, UK]. PCR was performed for 5 cycles
at an annealing temperature of 50 1C then for 25 cycles at an
annealing temperature of 73 1C. The amplified products were
inserted into pET-YSBLIC (kindly provided by Dr Mark Fogg of
the York Structural Biology Laboratory, York University, UK) via
ligation independent cloning, as described by Bonsor et al.23
Protein expression, purification and identification
Recombinant proteins were expressed from diﬀerent E. coli
BL21(DE3) strains as indicated in Table 3. Cells were grown at
37 1C with shaking at 200 rpm in 1 L LB medium supplemented
with 100 mg mL1 kanamycin for LIC-constructs transformed in
E. coli BL21(DE3) and 100 mg mL1 kanamycin plus 34 mg mL1
chloramphenicol for LIC-constructs transformed in E. coli
BL21(DE3) CodonPlus (RP/RIPL) to an absorbance of 0.6 at
600 nm. Induction was performed by the addition of isopropyl-
1-thio-b-D-galactopyranoside, to a concentration of 240 mg mL1,
followed by further incubation for 3 h and 18 h at 23 1C, 30 1C
and 37 1C, 100 rpm. Cells were harvested by centrifugation
(15 min, 4000  g, 4 1C), resuspended in 5 mL of 50 mM
Na2HPO4–HCl, 0.5 M NaCl, 10 mM imidazole, pH 7.4 followed
by cell disruption by sonication (6  10 s at 14 microns).
N-terminally hexahistidine tagged protein products were purified
via immobilised metal ion (Ni2+) chromatography (GE Healthcare,
UK) using a linear gradient of 10 to 500 mM imidazole. Protein
concentration and buffer exchange into 5 mM Tris–HCl (pH 8.0) of
the purified proteins was achieved using 30 kDa cut-off concen-
trator units [Vivaproducts, USA]. The purity of UDPG-SGTases was
judged by SDS-PAGE and Coomassie blue staining.24 Peptide
fragmentation fingerprinting of purified proteins was used to
Table 3 Primer pairs used for PCR and E. coli (DE3) strains used for expression. LIC-specific ends are shown in bold
Source organism and
UniProtKB accession number Primer pairs E. coli strain used for expression
S. cerevisiae Q06321 50-caccaccaccacatgATTGATGAGAATCCGCAC-30 BL21(DE3) CodonPlus (RP)
(Agilent Technologies, UK)50-gaggagaaggcgcgTTAAATCATCGTCCACCCTTCA-30
P. pastoris Q9Y751 50-caccaccaccacatgAACCAGTATTCTACGTCAGA-30 BL21(DE3) CodonPlus (RIPL)
(Agilent Technologies, UK)50-gaggagaaggcgcgTTACACTTCAAACCATGATC-30
M. guilliermondii A5DNB9 50-caccaccaccacatgTTAGAAGATTCACCACTCATC-30 BL21(DE3) CodonPlus (RP)
(Agilent Technologies, UK)50-gaggagaaggcgcgTTAGTCGTTAGTTGTCGTTG-30
P. angusta A7KAK6 50-caccaccaccacatgATAGAAGAGCATCCATTGACC-30 BL21(DE3) (Merck Chemicals, UK)
50-gaggagaaggcgcgttAAACCAGTAACCACGAGCC-30
K. lactis Q6CUV2 50-caccaccaccacatgGTTGAAAAAAACCCGTATT-30 BL21(DE3) (Merck Chemicals, UK)
50-gaggagaaggcgcgTTATATCAGAAGCCAGGATC-30
D. hansenii Q6BN88 50-caccaccaccacatgTTAGAAGATTCTCCATTCTAT-30 BL21(DE3) (Merck Chemicals, UK)
50-gaggagaaggcgcgttaTTATTTGTTAGCATCTGTAAC-30
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confirm the identity of the protein according to the methods
and criteria of Yang et al.25
UDPG-SGTase activity analysis
The purified enzymes were tested for selectivity using ergo-
sterol [Sigma-Aldrich, UK], cholesterol [Sigma-Aldrich, UK],
estrone [Sigma-Aldrich, UK], estradiol [Sigma-Aldrich, UK],
androstenedione [TCI, UK] and testosterone [Sigma-Aldrich,
UK] as steroidal acceptor substrates (Table 1 for chemical
structures of these steroids). In addition, b-naphthol, [Sigma-
Aldrich, UK] was used as a non-steroidal aromatic acceptor
substrate. All acceptor stock solutions were prepared in 100%
(v/v) ethanol. For TLC/LC-MS analysis, the assay mixture con-
tained (in a total volume of 100 mL) the following: 400 mM
acceptor, 360 mM UDP-glucose [Sigma-Aldrich, UK] or UDP-
galactose [Sigma-Aldrich, UK], 50 mM MnCl2 [Sigma-Aldrich,
UK] when appropriate, 2 mg purified enzyme and 10 mM
Na2HPO4–HCl, pH 7.8. The assays were performed in triplicate
and terminated after 2 h incubation at 30 1C. The identity of the
testosterone glucoside was confirmed by comparison with an
authentic standard kindly provided by ProStrakan Group Plc,
UK. Assays for TLC analysis were terminated by the addition of
0.9 mL of 0.45% (w/v) NaCl and 4 mL of chloroform–methanol
(2 : 1, v/v), 2 mL separated on silica gel 60 TLC plates [Merck
Chemicals, UK] according to the procedure described in
Warnecke et al.8 and visualised by spraying with 15% (w/v)
phosphotungstic acid followed by charring using a heat gun.
Assays for LC-MS analysis were only performed with testosterone
and were terminated by the addition of 100 mL of 0.3 MHCl, then
diluted with 800 mL of 18.2 MO cm1 water and 20 mL applied to
a Phenomenex Luna 5 mm CN column (5.0 cm  2 mm).
Isocratic reverse phase separation was achieved in 5 min with
a flow rate of 150 mL min1 of 30% (v/v) acetonitrile, 1% (v/v)
acetic acid mobile phase and the analytes detected using a
ThermoFinnigan LCQ Advantage ion-trap mass-spectrometer
in selected ion monitoring mode with a spray voltage of 4.5 kV,
capillary voltage of 5 V and capillary temperature of 230 1C. For
kinetic analysis, the assay mixture contained (in a total volume
of 75 mL) the following: acceptor (cholesterol or testosterone)
ranging from 12.5–200 mM, 50 000 dpm UDP-[14C] glucose (final
concentration 0.88 mM, specific activity 302 mCi mmol1,
Perkin Elmer, UK), 0.5 mg purified enzyme diluted in 10 mM
Na2HPO4–HCl, pH 7.8. After incubation for 20 min at 30 1C, the
reaction was terminated by the addition of 125 mL 0.45% (w/v)
NaCl followed by extraction using 300 mL of water-saturated
ethyl acetate. For each sample, 150 mL of the organic layer was
counted for 3 min by liquid scintillation counting using the
Tricarb 2200 CA (Perkin Elmer, UK).
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